A phase II study of vinblastine in combination with acrivastine in patients with advanced renal cell carcinoma. (Q53019740)

From Wikidata

Jump to navigation Jump to search

scientific article published in January 1994

Language	Label	Description	Also known as
English	A phase II study of vinblastine in combination with acrivastine in patients with advanced renal cell carcinoma.	scientific article published in January 1994

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/7860231

A phase II study of vinblastine in combination with acrivastine in patients with advanced renal cell carcinoma. (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/7860231

1 reference

ChEBI release 2020-05-28

1 reference

based on heuristic

inferred from title

author name string

J Berlin

1

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/7860231

A C King

2

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/7860231

K Tutsch

3

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/7860231

J W Findlay

4

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/7860231

P Kohler

5

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/7860231

M Collier

6

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/7860231

N J Clendeninn

7

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/7860231

G Wilding

8

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/7860231

publication date

1 January 1994

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/7860231

Investigational New Drugs

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/7860231

12

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/7860231

2

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/7860231

137-141

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/7860231

Solid-phase extraction of vinblastine and vincristine from plasma and urine: variable drug recoveries due to non-reproducible column packings

1 reference

https://pubmed.ncbi.nlm.nih.gov/7860231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical modulation of doxorubicin resistance by the calmodulin-inhibitor, trifluoperazine: a phase I/II trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/7860231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil

1 reference

https://pubmed.ncbi.nlm.nih.gov/7860231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative gas chromatographic-mass spectrometric analysis of acrivastine and a metabolite in human plasma

1 reference

https://pubmed.ncbi.nlm.nih.gov/7860231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circumvention of Multidrug Resistance Mediated by P-170 Glycoprotein Using Calcium Antagonists in Primary Human Renal Cell Carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/7860231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical trial of continuous infusion verapamil, bolus vinblastine, and continuous infusion VP-16 in drug-resistant pediatric tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/7860231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/7860231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms and modulation of multidrug resistance in primary human renal cell carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7860231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of etoposide with cyclosporine as a modulator of multidrug resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/7860231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intrinsic drug resistance in human kidney cancer is associated with expression of a human multidrug-resistance gene.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7860231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of Advanced Renal Cell Carcinoma—Traditional Methods and Innovative Approaches

1 reference

https://pubmed.ncbi.nlm.nih.gov/7860231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I and pharmacological study of vinblastine by prolonged continuous infusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/7860231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of vinca alkaloids in plasma and urine using high-performance liquid chromatography with electrochemical detection

1 reference

https://pubmed.ncbi.nlm.nih.gov/7860231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacology of drugs that alter multidrug resistance in cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7860231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current status of the therapy of advanced renal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/7860231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00874444

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/7860231

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/7860231

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53019740&oldid=2211948892"